Insulin delivery with FlexPen: dose accuracy, patient preference and adherence

Expert Opinion on Drug Delivery
Andreas PfütznerWc Lee

Abstract

The introduction of insulin pens has helped improve adherence in Type 1 or 2 diabetes, and reduce inaccurate dosing, fear of injection, and social embarrassment associated with vial and syringe. This report presents the published evidence base for the accuracy, patient preference and economic evaluation of one prefilled pen, FlexPen (Novo Nordisk A/S, Bagsvaerd, Denmark) and discusses recent changes to the design of this pen. Primary research publications that included the study of FlexPen were identified from various sources. Several studies have shown that FlexPen delivers high, medium and low doses of insulin significantly more accurately than vial and syringe, SoloStar (sanofi-aventis, Paris, France) or OptiClik (sanofi-aventis, Paris, France). Patients have also found FlexPen easier to use than vial and syringe. A Next Generation FlexPen has been developed, which maintains the demonstrated accuracy of FlexPen and is accompanied by a reduced injection force for simpler and more comfortable use, and clear colour scheme for insulin type to avoid medication errors.

References

Jan 1, 1993·Diabetic Medicine : a Journal of the British Diabetic Association·D ZieglerF Lessmann
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Jun 1, 1995·Diabetes Research and Clinical Practice·C CoscelliG A Coronel
Jun 9, 1998·Journal of Diabetes and Its Complications·W SchadyA J Boulton
Oct 15, 1998·Archives of Disease in Childhood·M G GnanalinghamC P Smith
May 20, 1999·Diabetes Care·R E GlasgowD J Cox
Jan 7, 2000·Diabetes Research and Clinical Practice·A ZambaniniM D Feher
Sep 13, 2001·Diabetic Medicine : a Journal of the British Diabetic Association·E D MollemaH M van der Ploeg
May 22, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Resea
Nov 9, 2004·Clinical Therapeutics·Kent H SummersSheila M Lenox
Jun 23, 2005·Current Medical Research and Opinion·Jennifer M LeeChris L Pashos
Sep 24, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·M PeyrotS E Skovlund
Mar 8, 2006·Clinical Therapeutics·Mary KorytkowskiToshinari Asakura
Nov 30, 2006·Diabetes & Metabolism·V Lassmann-Vague, D Raccah
Mar 6, 2007·Expert Opinion on Drug Delivery·Alastair Clarke, Geralyn Spollett
May 17, 2007·QJM : Monthly Journal of the Association of Physicians·L A DonnellyUNKNOWN DARTS/MEMO collaboration
Sep 21, 2007·Advanced Drug Delivery Reviews·El-Sayed KhafagyKozo Takayama
Oct 24, 2007·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Jerome E Thurman
Apr 11, 2008·Current Medical Research and Opinion·Toshinari AsakuraNoriaki Yohkoh
Aug 5, 2008·Current Medical Research and Opinion·A PfütznerC Jørgensen
Aug 20, 2008·Expert Opinion on Pharmacotherapy·J RisslerN-A Hansen
Aug 20, 2008·Expert Opinion on Pharmacotherapy·B SommavillaKh Jensen
May 1, 2008·Journal of Diabetes Science and Technology·Heike HänelAndreas Pfützner

❮ Previous
Next ❯

Citations

Jun 11, 2010·Diabetes Technology & Therapeutics·Y M Luijf, J H DeVries
Jun 15, 2012·Diabetes Technology & Therapeutics·Meike KrzywonMona Abdel-Tawab
Sep 22, 2011·Journal of Pediatric Endocrinology & Metabolism : JPEM·Anne-Marie KappelgaardGitte Schøning Fuchs
May 10, 2011·Expert Opinion on Drug Delivery·Michel ChristenHeiko Müller
Sep 8, 2010·Current Medical Research and Opinion·L Niskanen
Feb 16, 2010·Current Medical Research and Opinion·M KrzywonM Schubert-Zsilavecz
Oct 13, 2011·Current Medical Research and Opinion·S GargD Pollom
Jul 16, 2010·Diabetes Research and Clinical Practice·Kupper A WintergerstMichael B Foster
Apr 13, 2011·Pediatric Diabetes·Ragnar HanasBarbara Anderson
Jan 27, 2015·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Arnd FriedrichsSteffen Adler
Sep 13, 2014·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Balduino TschiedelFrank Flacke
Sep 17, 2016·Expert Opinion on Drug Delivery·Fabien JeannerotJoan Schertz
Jan 10, 2012·Journal of Diabetes Science and Technology·Barbara J Anderson, Maria J Redondo
Oct 6, 2010·Journal of Diabetes Science and Technology·Sherwyn Schwartz
Oct 27, 2011·Journal of Diabetes Science and Technology·Arnd FriedrichsSteffen Adler
May 31, 2014·Journal of Diabetes Science and Technology·Hitomi FujiiMasafumi Kitaoka
Nov 30, 2016·Journal of Diabetes Science and Technology·David C KlonoffCatherine Domenger
Jun 2, 2010·Journal of Diabetes Science and Technology·Ann S Williams, Patrick A Schnarrenberger
Oct 16, 2013·Journal of Diabetes Science and Technology·Arnd FriedrichsMona Abdel-Tawab
Mar 1, 2018·Journal of Diabetes Science and Technology·Darlene M DreonMeng H Tan
Mar 7, 2017·Journal of Diabetes Science and Technology·Andreas Pfützner
Aug 6, 2013·Journal of Diabetes Science and Technology·Janine BohnetMona Abdel-Tawab
Oct 1, 2008·Postgraduate Medicine·Henry Howard Goldstein

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.